XML 29 R18.htm IDEA: XBRL DOCUMENT v3.25.2
Segments and Disaggregated Revenue
6 Months Ended
Jun. 30, 2025
Segments and Disaggregated Revenue [Abstract]  
Segments and Disaggregated Revenue
12. Segments and Disaggregated Revenue

  

The Company’s Chief Operating Decision Maker (“CODM”) as defined under GAAP, who is the Company’s Chief Financial Officer and Chief Executive Officer, has determined that the Company is currently organized its operations into the segments as follows. We have organized our operations into three segments: Construction, Medical, Development and Environmental. We allocate to segment results the operating expenses “Payroll and related expenses,” “General and administrative,” “Marketing and business development,” and “Pre-project” based on usage, which is generally reflected in the segment in which the costs are incurred. These segments reflect the way our executive team evaluates the Company’s business performance and manages its operations. The Construction segment includes the Company’s manufacturing unit SG ECHO and other modules projects. The Medical segment mainly consists of minimal expenses for this segment. The Environmental segment has had no activity through December 31, 2024. Corporate and support consists of general corporate expenses such as our executive office; the corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups; corporate overhead and other items not allocated to any of the Company’s segments. From time to time, the Company revises the measurement of each segment’s cost of revenue and operating expenses, including any corporate overhead allocations, as determined by the information regularly reviewed by its executive team. The CODM continually reviews a monthly statement of operations separated by segment, along with an analysis of the significant segment expenses as described below. Information for the Company’s segments, as well as for Corporate and support, is provided in the following table: 

 

   Construction   Medical   Corporate
and support
   Oil and
Gas
   Consolidated 
Three Months Ended June 30, 2025                    
Revenue  $523,558   $
   $
    197,793   $721,351 
                          
Significant segment expenses:                         
Costs of revenue:                         
Direct labor   204,330    
    
    50,000    254,330 
Materials   438,146    
    
    7,529    445,675 
Allocated overhead   655,939    
    
    247,862    903,801 
Other costs of revenue   112,013    
    
    
    112,013 
    1,410,428    
    
    305,931    1,715,819 
Operating expenses:                         
Payroll and related   50,312    
    415,324    272,158    737,794 
Professional fees   
    
    949,992    519,465    1,469,457 
Other expenses   10,937    140    186,493    288,491    486,061 
    61,249    140    1,551,809    1,080,114    2,693,312 
Operating loss   (948,119)   (140)   (1,551,809)   (1,187,712)   (3,687,780 
Other expense   (113,656)   
    (511,959)   (260,475)   (886,090)
Net loss  $(1,061,775)  $(140)  $(2,063,768)  $(1,448,187)  $(4,573,870)
                          
Total assets  $5,428,040   $1,406   $28,089,142    20,345,088   $53,863,675 
Depreciation and amortization  $56,830   $
   $652    200,331   $257,812 

 

   Construction   Medical   Corporate and support   Consolidated 
Three Months Ended June 30, 2024                
Revenue  $1,211,254   $
   $
   $1,211,245 
                     
Significant segment expenses:                    
Cost of revenue                    
Direct Labor   27,971    
    
    27,971 
Materials   304,048    
    
    304,048 
Allocated overhead   595,157    
    
    595,157 
Other costs of revenue   167,073    
    
    167,073 
    1,094,249    
    
    1,094,249 
Operating expenses:                    
Payroll and related   
    
    1,134,084    1,134,084 
Professional fees   
    
    672,705    672,705 
Other expenses   91,281    50,076    59,983    201,249 
    91,281    50,076    1,866,682    2,008,039 
Operating income (loss)   25,724    (50,076)   (1,866,682)   (1,891,034)
Other expense   (137,955)   
    (2,648,011)   (2,785,966)
Net loss  $(112,231)  $(50,076)  $(4,514,693)  $(4,677,000)
Total assets  $5,479,525   $1,406   $2,793,342   $8,274,273 
Depreciation and amortization  $6,484   $
   $1,807   $8,291 
   Construction   Medical   Corporate
and support
   Oil and gas   Consolidated 
Six Months Ended June 30, 2025                    
Revenue  $1,019,637   $
   $
    268,068   $1,287,705 
                          
Significant segment expenses:                         
Costs of revenue:                         
Direct labor   392,423    
    
    50,000    442,423 
Materials   583,019    
    
    7,528    590,549 
Allocated overhead   1,136,267    
    
    252,487    1,388,773 
Other costs of revenue   153,164    
    
    31,020    184,183 
    2,264,873    
    
    341,035    2,605,928 
Operating expenses:                         
Payroll and related   50,312    
    855,193    388,027    1,293,532 
Professional fees   
    
    1,552,634    519,465    2,630,190 
Other expenses   12,002    967    326,779    496,160    157,817 
    62,314    967    2,734,606    1,403,652    4,201,539 
Operating loss   (1,307,550)   (967)   (2,734,606)   (1,476,639)   (5,519,762)
Other expense   (264,031)   
    (1,224,516)   (312,229)   (1,800,776)
Net loss  $(1,571,581)  $(967)  $(3,959,122)   (1,788,868)  $(7,320,538)
                          
Total assets  $5,428,040   $1,406   $27,969,142   $20,345,088   $53,743,675 
Depreciation and amortization  $103,691   $
   $1,272    259,577   $364,539 
Capital expenditure   
    
    
    
    
 

 

   Construction   Medical   Corporate
and support
   Consolidated 
Six Months Ended June 30, 2024                
Revenue  $2,179,369   $
   $
   $2,179,369 
                     
Significant segment expenses:                    
  Costs of revenue:                    
    Direct labor   27,971    
    
    27,971, 
    Materials   351,646    
    
    351,646 
    Allocated overhead   1,163,247    
    
    1,163,247 
    Other costs of revenue   196,368    
    
    196,368 
    1,739,232    
    
    1,739,232 
Operating expenses:                    
  Payroll and related   
    
    2,386,006    2,386,066 
  Professional fees   
    
    1,237,944    1,237,944 
  Other expenses   91,814    85,960    60,030    237,744 
    91,814    85,960    3,683,980    3,861,754 
Operating income (loss)   348,323    (85,960)   (3,683,980)   (3,421,617)
Other expense   (187,908)   
    (6,550,035)   (6,737,943 
Income (loss) before income taxes   160,415    (85,960)   (10,234,015)   (10,159,560)
Common stock deemed dividend   
    
    (1,638,149)   (1,638,149)
Income from discontinued operations   
    
    2,684,678    2,684,678 
Net income (loss) attributable to common stockholders  $160,415   $(85,960)  $(9,187,486)  $(9,113,031)
                     
Total assets  $5,479,525   $1,406   $2,793,342   $8,274,273 
Depreciation and amortization  $81,547   $
   $3,487   $85,034 
Capital expenditure   7,873    
         7,873